IP Library Assignment 024430/0623
Patent Assignment
Reel/Frame 024430/0623

Corrective Assignment to Correct the Receiving Party Name Previously Recorded on Reel 024407 Frame 0158. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2010-05-24 Pages: 8
Assignors
COLCA, GERARD R.
Executed: 2010-05-07
GADWOOD, ROBERT C.
Executed: 2010-05-11
PARKER, TIM
Executed: 2010-05-11
Assignee
METABOLIC SOLUTIONS DEVELOPMENT COMPANY
161 EAST MICHIGAN AVENUE, 4TH FLOOR, KALAMAZOO, MICHIGAN, 49007
Covered Property (1)
Thiazolidinedione Analogues for the Treatment of Metabolic Diseases
Patent: 8,067,450 →
Application: 12/677,541 →
Publication: US 2010/0222399
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 19, 2010
From: COLCA, GERARD R.; GADWOOD, ROBERT C.; PARKER, TIM
To: METABOLIC SOULTIONS DEVELOPMENT COMPANY
Reel/Frame 024407/0158 →
Security Agreement Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
Release of Security Interest May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
Assignment of Assignor's Interest Jun 23, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: OCTETA THERAPEUTICS, LLC
Reel/Frame 038996/0394 →
Change of Name May 12, 2017
From: OCTETA THERAPEUTICS, LLC
To: CIRIUS THERAPEUTICS, INC.
Reel/Frame 042457/0520 →